Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunctionWeier Qi, George L. King, Monika A. Niewczas et al.|Nature Medicine|2017Cited by 493
Glomerular VEGF resistance induced by PKCδ/SHP‐1 activation and contribution to diabetic nephropathyAkira Mima, George L. King, Munehiro Kitada et al.|The FASEB Journal|2012Cited by 102
Induction of Vascular Insulin Resistance and Endothelin-1 Expression and Acceleration of Atherosclerosis by the Overexpression of Protein Kinase C-β Isoform in the EndotheliumQian Li, George L. King, Kyoungmin Park et al.|Circulation Research|2013Cited by 91
PKCδ inhibition normalizes the wound-healing capacity of diabetic human fibroblastsMogher Khamaisi, George L. King, Sayaka Katagiri et al.|Journal of Clinical Investigation|2016Cited by 89
Characterization of Glycolytic Enzymes and Pyruvate Kinase M2 in Type 1 and 2 Diabetic NephropathyDaniel Gordin, George L. King, Hetal Shah et al.|Diabetes Care|2019Cited by 88